Disclosed is a product comprising (S,S)-reboxetine and one or more neuroleptic agents selected from clozapine, olanzapine, risperidone, ziprasidone and quetiapine and mixtures thereof. The product can be used in the manufacture of a medicament for treating or preventing diseases of the central nervous system.
Norepinephrine reuptake inhibitor i.e. reboxetine and neuroleptic to treat disorders of the central nervous system